![Ciara C. O’Sullivan of Mayo Clinic, leads the Alliance A011801 trial – Alliance for Clinical Trials in Oncology](https://oncodaily.com/pub/uploads/2024/05/1715790000461_e526f25003784e65a9cb3fbe708852c6-1280x720.jpeg)
Photo from Alliance for Clinical Trials in Oncology/LinkedIn
May 17, 2024, 13:16
Ciara C. O’Sullivan of Mayo Clinic, leads the Alliance A011801 trial – Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology shared on LinkedIn:
“For Trial Tuesday, Ciara C. O’Sullivan, MB, BCh, of Mayo Clinic, leads the Alliance A011801 (CompassHER2 RD) trial to see how targeted therapy linked to a chemotherapy drug works to prevent breast cancer from returning in patients with high-risk HER2+ breast cancer. To learn more about the CompassHER2 RD trial.”
Further Reading.
Source: Alliance for Clinical Trials in Oncology/LinkedIn